24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Impact of Cardiovascular Neurohormones on Onset of Vasovagal Syncope Induced by Head‐up Tilt

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Vasovagal reflex is the most common form of syncope, but the pathophysiological mechanisms that initiate the reflex are not well understood. We aimed to study supine and early orthostatic levels of the neurohormones involved in control of circulatory homeostasis in relation to the onset of tilt‐induced vasovagal syncope (VVS).

          Methods and Results

          A total of 827 patients who were investigated for unexplained syncope with head‐up tilt test (HUT) and optional nitroglycerin provocation (Italian protocol) had blood samples collected while supine and after 3‐minutes of HUT. Of these, 173 (20.9%) patients developed VVS during drug‐free HUT, 161 of whom (males 44.7%; age 45±21 years) had complete data. We analyzed levels of epinephrine, norepinephrine, C‐terminal pro–arginine vasopressin, C‐terminal endothelin‐1, and midregional fragments of pro–atrial natriuretic peptide and pro‐adrenomedullin in relation to time from tilt‐up to onset of VVS. We applied a linear regression model adjusted for age and sex. The mean time to syncope was 11±7 minutes. Older age (β=0.13; SE=0.03, P<0.001), higher supine systolic blood pressure (β=0.06; SE=0.03, P=0.02), and higher supine midregional fragment of pro‐adrenomedullin predicted longer time to syncope (β=2.31; SE=0.77, P=0.003), whereas supine levels of other neurohormones were not associated with time to syncope. Among 151 patients who developed VVS later than 3 minutes of HUT, increase in epinephrine (β=−3.24; SE=0.78, P<0.001) and C‐terminal pro–arginine vasopressin (β=−2.07; SE=0.61, P=0.001) at 3 minutes of HUT were related to shorter time to syncope.

          Conclusions

          Older age, higher blood pressure, and higher level of pro‐adrenomedullin are associated with later onset of VVS during tilt testing, whereas greater increase of tilt‐induced epinephrine and vasopressin release correlate with shorter time to syncope.

          Abstract

          See Editorial Williford et al

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.

          Adrenomedullin (ADM) is a potent vasodilatory peptide, and circulating concentrations have been described for several disease states, including dysfunction of the cardiovascular system and sepsis. Reliable quantification has been hampered by the short half-life, the existence of a binding protein, and physical properties. Here we report the technical evaluation of an assay for midregional pro-ADM (MR-proADM) that does not have these problems. MR-proADM was measured in a sandwich immunoluminometric assay using 2 polyclonal antibodies to amino acids 45-92 of proADM. The reference interval was defined in EDTA plasma of 264 healthy individuals (117 male, 147 female), and increased MR-proADM concentrations were found in 95 patients with sepsis and 54 patients with cardiovascular disease. The assay has an analytical detection limit of 0.08 nmol/L, and the interassay CV was 0.12 nmol/L. The assay was linear on dilution with undisturbed recovery of the analyte. EDTA-, heparin-, and citrate-plasma samples were stable (<20% loss of analyte) for at least 3 days at room temperature, 14 days at 4 degrees C, and 1 year at -20 degrees C. MR-proADM values followed a gaussian distribution in healthy individuals with a mean (SD) of 0.33 (0.07) nmol/L (range, 0.10-0.64 nmol/L), without significant difference between males or females. The correlation coefficient for MR-proADM vs age was 0.50 (P < 0.001). MR-proADM was significantly (P < 0.001) increased in patients with cardiovascular disease [median (range), 0.56 (0.08-3.9) nmol/L] and patients with sepsis [3.7 (0.72-25.4) nmol/L]. MR-proADM is stable in plasma of healthy individuals and patients. MR-proADM measurements may be useful for evaluating patients with sepsis, systemic inflammation, or heart failure.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Nexfin noninvasive continuous blood pressure validated against Riva-Rocci/Korotkoff.

            The Finapres methodology offers continuous measurement of blood pressure (BP) in a noninvasive manner. The latest development using this methodology is the Nexfin monitor. The present study evaluated the accuracy of Nexfin noninvasive arterial pressure (NAP) compared with auscultatory BP measurements (Riva-Rocci/Korotkoff, RRK). In supine subjects NAP was compared to RRK, performed by two observers using an electronic stethoscope with double earpieces. Per subject, three NAP-RRK differences were determined for systolic and diastolic BP, and bias and precision of differences were expressed as median (25th, 75th percentiles). Within-subject precision was defined as the (25th, 75th percentiles) after removing the average individual difference. A total of 312 data sets of NAP and RRK for systolic and diastolic BP from 104 subjects (aged 18-95 years, 54 males) were compared. RRK systolic BP was 129 (115, 150), and diastolic BP was 80 (72, 89), NAP-RRK differences were 5.4 (-1.7, 11.0) mm Hg and -2.5 (-7.6, 2.3) mm Hg for systolic and diastolic BP, respectively; within-subject precisions were (-2.2, 2.3) and (-1.6, 1.5) mm Hg, respectively. Nexfin provides accurate measurement of BP with good within-subject precision when compared to RRK.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope.

              Head-up tilt testing potentiated by sublingual nitroglycerin (NTG), advocated by an Italian group, is a simple and safe but still not a standardized, diagnostic tool for the investigation of syncope. In fact, owing to its rapid spread, the original protocol received, often arbitrarily, many subsequent modifications. We now define the best methodology of the test on strictly evidence-based criteria as: stabilization phase of 5 min in the supine position; passive phase of 20 min at a tilt angle of 60 degrees; provocation phase of further 15 min after 400 micrograms NTG sublingual spray. Test interruption is made when the protocol is completed in the absence of symptoms, or there is occurrence of syncope, or occurrence of progressive (> 5 min) orthostatic hypotension. We intend that this protocol, named by us as 'The Italian Protocol', will be accepted as the standard methodology of the tilt test potentiated by sublingual nitrates.
                Bookmark

                Author and article information

                Contributors
                artur.fedorowski@med.lu.se
                Journal
                J Am Heart Assoc
                J Am Heart Assoc
                10.1002/(ISSN)2047-9980
                JAH3
                ahaoa
                Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
                John Wiley and Sons Inc. (Hoboken )
                2047-9980
                18 June 2019
                18 June 2019
                : 8
                : 12 ( doiID: 10.1002/jah3.2019.8.issue-12 )
                : e012559
                Affiliations
                [ 1 ] Department of Clinical Sciences Lund University Malmö Sweden
                [ 2 ] Department of Clinical Physiology Skåne University Hospital Malmö Sweden
                [ 3 ] Department of Neuroscience, Imaging and Clinical Sciences “G. d'Annunzio” University Chieti Italy
                [ 4 ] Fondazione Villa Serena per la Ricerca Città Sant'Angelo Italy
                [ 5 ] Department of Internal Medicine Skåne University Hospital Malmö Sweden
                [ 6 ] National Heart and Lung Institute Imperial College Hammersmith Hospital Campus London United Kingdom
                [ 7 ] Cardiac Arrhythmia Center Cardiovascular Division University of Minnesota Minneapolis MN
                [ 8 ] Department of Cardiology Skåne University Hospital Malmö Sweden
                Author notes
                [*] [* ] Correspondence to: Artur Fedorowski, MD, PhD, Department of Cardiology, Carl‐Bertil Laurells gata 9, Skåne University Hospital, 214 28 Malmö, Sweden. E‐mail: artur.fedorowski@ 123456med.lu.se
                Article
                JAH34140
                10.1161/JAHA.119.012559
                6645642
                31208249
                7f706356-e46a-4181-ab5d-24a9b7c6680d
                © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 07 March 2019
                : 26 April 2019
                Page count
                Figures: 4, Tables: 3, Pages: 8, Words: 4929
                Categories
                Original Research
                Original Research
                Arrhythmia and Electrophysiology
                Custom metadata
                2.0
                jah34140
                18 June 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.4 mode:remove_FC converted:18.06.2019

                Cardiovascular Medicine
                autonomic function,biomarker,neurocardiology,syncope,electrophysiology
                Cardiovascular Medicine
                autonomic function, biomarker, neurocardiology, syncope, electrophysiology

                Comments

                Comment on this article